Toolkit/apparent diffusion coefficient map

apparent diffusion coefficient map

Assay Method·Research·Since 2025

Also known as: ADC map, ADC maps

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

The study aimed to evaluate the accuracy of... apparent diffusion coefficient (ADC) maps... Diffusion restriction was observed on DWI and ADC map sequences in 43 (86%) of the cases.

Usefulness & Problems

Why this is useful

ADC maps are used with diffusion-weighted imaging to evaluate diffusion restriction in prostate lesions. The abstract reports diffusion restriction on DWI and ADC map sequences in 86% of cases.; assessing diffusion restriction in prostate lesions; lesion characterization within prostate MRI

Source:

ADC maps are used with diffusion-weighted imaging to evaluate diffusion restriction in prostate lesions. The abstract reports diffusion restriction on DWI and ADC map sequences in 86% of cases.

Source:

assessing diffusion restriction in prostate lesions

Source:

lesion characterization within prostate MRI

Problem solved

It supports lesion characterization by providing diffusion-related information associated with prostate cancer.; provides diffusion-derived imaging information associated with malignant prostate lesions

Source:

It supports lesion characterization by providing diffusion-related information associated with prostate cancer.

Source:

provides diffusion-derived imaging information associated with malignant prostate lesions

Problem links

provides diffusion-derived imaging information associated with malignant prostate lesions

Literature

It supports lesion characterization by providing diffusion-related information associated with prostate cancer.

Source:

It supports lesion characterization by providing diffusion-related information associated with prostate cancer.

Published Workflows

Objective: Evaluate the role and accuracy of biparametric MRI in patients with prostate cancer for diagnosis, extent assessment, and post-treatment early recurrence monitoring.

Why it works: The study evaluates MRI sequence findings in lesions that were later pathologically confirmed as prostate cancer, using pathology as the reference to assess how often specific MRI features are present in malignant lesions.

T2-weighted lesion hypointensitydiffusion restriction on DWI and ADC mapsT1-weighted lesion signal characterizationbiparametric MRIretrospective cohort analysispathology confirmation by biopsy or surgical resection

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete measurement method used to characterize an engineered system.

Target processes

No target processes tagged yet.

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor

This requires MRI diffusion imaging and generation or interpretation of ADC maps. The study uses pathology-confirmed cancer cases as the reference set.; requires MRI diffusion acquisition and ADC map generation

The abstract does not provide a standalone ADC accuracy estimate or define thresholds for interpretation. It also does not compare ADC-based assessment directly with mpMRI.; abstract reports ADC maps together with DWI rather than as a separate performance result

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Observations

successHuman Clinicaltherapeutic use

MRI

Inferred from claim c3 during normalization. Diffusion restriction was observed on diffusion-weighted imaging and ADC map sequences in 43 of 50 pathology-confirmed prostate cancer cases. Derived from claim c3. Quoted text: Diffusion restriction was observed on DWI and ADC map sequences in 43 (86%) of the cases.

Source:

cases with diffusion restriction on DWI and ADC maps43 casescases with diffusion restriction on DWI and ADC maps86 %total evaluated cases50 cases

Supporting Sources

Ranked Claims

Claim 1conclusionsupports2025Source 1needs review

The study concludes that T2-weighted imaging has high accuracy in diagnosing malignant prostate lesions.

The findings of this study confirm the high accuracy of T2WI in diagnosing malignant prostate lesions.
Claim 2diagnostic performancesupports2025Source 1needs review

Diffusion restriction was observed on diffusion-weighted imaging and ADC map sequences in 43 of 50 pathology-confirmed prostate cancer cases.

Diffusion restriction was observed on DWI and ADC map sequences in 43 (86%) of the cases.
cases with diffusion restriction on DWI and ADC maps 43 casescases with diffusion restriction on DWI and ADC maps 86 %total evaluated cases 50 cases
Claim 3diagnostic performancesupports2025Source 1needs review

T2-weighted imaging showed hypointense lesions in 46 of 50 pathology-confirmed prostate cancer cases.

On T2WI, the lesions appeared hypointense in 46 (92%) of the 50 cases.
cases with hypointense lesions on T2WI 46 casescases with hypointense lesions on T2WI 92 %total evaluated cases 50 cases
Claim 4signal characterizationsupports2025Source 1needs review

On T1-weighted imaging, prostate cancer lesions were isointense in 47 of 50 cases and moderately hyperintense in 3 of 50 cases, particularly for lesions larger than 8 mm.

On T1WI, cancerous lesions were isointense in 47 (94%) cases and moderately hyperintense in three (6%) cases, particularly in lesions larger than 8 mm in diameter.
isointense lesions on T1WI 47 casesisointense lesions on T1WI 94 %lesion size association >8 mmmoderately hyperintense lesions on T1WI 3 casesmoderately hyperintense lesions on T1WI 6 %
Claim 5study objectivesupports2025Source 1needs review

This study evaluated the role and accuracy of biparametric MRI in prostate cancer for diagnosis, extent assessment, and post-treatment early recurrence monitoring.

This study aims to evaluate the role and accuracy of bpMRI in patients with prostate cancer, particularly for diagnosing clinically significant cancer, assessing its extent, and monitoring patients post-treatment for early recurrence.

Approval Evidence

1 source1 linked approval claimfirst-pass slug apparent-diffusion-coefficient-map
The study aimed to evaluate the accuracy of... apparent diffusion coefficient (ADC) maps... Diffusion restriction was observed on DWI and ADC map sequences in 43 (86%) of the cases.

Source:

diagnostic performancesupports

Diffusion restriction was observed on diffusion-weighted imaging and ADC map sequences in 43 of 50 pathology-confirmed prostate cancer cases.

Diffusion restriction was observed on DWI and ADC map sequences in 43 (86%) of the cases.

Source:

Comparisons

Source-stated alternatives

The paper evaluates ADC maps alongside DWI, T2WI, and T1WI. These are components considered within the broader bpMRI setting.

Source:

The paper evaluates ADC maps alongside DWI, T2WI, and T1WI. These are components considered within the broader bpMRI setting.

Source-backed strengths

participated in detection of diffusion restriction in most cases in this cohort

Source:

participated in detection of diffusion restriction in most cases in this cohort

The paper evaluates ADC maps alongside DWI, T2WI, and T1WI. These are components considered within the broader bpMRI setting.

Shared frame: source-stated alternative in extracted literature

Strengths here: participated in detection of diffusion restriction in most cases in this cohort.

Relative tradeoffs: abstract reports ADC maps together with DWI rather than as a separate performance result.

Source:

The paper evaluates ADC maps alongside DWI, T2WI, and T1WI. These are components considered within the broader bpMRI setting.

Compared with T1-weighted imaging

The paper evaluates ADC maps alongside DWI, T2WI, and T1WI. These are components considered within the broader bpMRI setting.

Shared frame: source-stated alternative in extracted literature

Strengths here: participated in detection of diffusion restriction in most cases in this cohort.

Relative tradeoffs: abstract reports ADC maps together with DWI rather than as a separate performance result.

Source:

The paper evaluates ADC maps alongside DWI, T2WI, and T1WI. These are components considered within the broader bpMRI setting.

Compared with T2-weighted imaging

The paper evaluates ADC maps alongside DWI, T2WI, and T1WI. These are components considered within the broader bpMRI setting.

Shared frame: source-stated alternative in extracted literature

Strengths here: participated in detection of diffusion restriction in most cases in this cohort.

Relative tradeoffs: abstract reports ADC maps together with DWI rather than as a separate performance result.

Source:

The paper evaluates ADC maps alongside DWI, T2WI, and T1WI. These are components considered within the broader bpMRI setting.

Ranked Citations

  1. 1.

    Extracted from this source document.